Summary of the conclusions

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages

  Holgate, S T ^a   Church, M K ^a   Howarth, P H ^a   Simons, F E R ^a   Campbell, A ^a   Dunn, N ^a   Routledge, P ^a   Hindmarch, I ^a   Timmerman, H ^a   Camm, J ^a   Friedmann, P ^a   Canonica, W ^a   Scadding, G ^a   Devalia, J ^a   Renwick, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BRADYKININ ANTAGONIST; CETIRIZINE; CORTICOSTEROID; GLYCOPROTEIN P; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; PEPTIDOLEUKOTRIENE; POTASSIUM CHANNEL;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; ATOPIC DERMATITIS; BLOOD BRAIN BARRIER; CARDIOTOXICITY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG METABOLISM; DRUG PENETRATION; DRUG PROTEIN BINDING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHINITIS; SEDATION; URTICARIA;

EID: 0032807692     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)